Carcinoma News and Research

RSS
Carcinoma is cancer that begins in the skin or in tissues that line or cover internal organs.
NCI awards Altor Bioscience a $3 MM grant to develop its targeted cancer therapeutic ALT-801

NCI awards Altor Bioscience a $3 MM grant to develop its targeted cancer therapeutic ALT-801

Huachansu may slow cancer progression

Huachansu may slow cancer progression

Phase 1 extension study results of Plexxikon's PLX4032 in metastatic melanoma patients encouraging

Phase 1 extension study results of Plexxikon's PLX4032 in metastatic melanoma patients encouraging

Drug trial for OSI-906 begins

Drug trial for OSI-906 begins

Bayer's regorafenib showed 50% stabilization rate in RCC patients

Bayer's regorafenib showed 50% stabilization rate in RCC patients

Study on mice reveals that short term stress can prevent cancer

Study on mice reveals that short term stress can prevent cancer

Study reveals that patients with NSCLC who received maintenance therapy with ALIMTA showed survival benefit

Study reveals that patients with NSCLC who received maintenance therapy with ALIMTA showed survival benefit

FDA continues review of BSD Medical's HDE for the BSD-2000 Hyperthermia System

FDA continues review of BSD Medical's HDE for the BSD-2000 Hyperthermia System

Study reveals microRNAs affect tumor progression

Study reveals microRNAs affect tumor progression

Notice of Allowance issued by PTO for OSI's EGFR drug

Notice of Allowance issued by PTO for OSI's EGFR drug

Nimotuzumab drug approved for Mexican distribution

Nimotuzumab drug approved for Mexican distribution

Study reveals that YAP can be used for the diagnosis of gastric carcinoma

Study reveals that YAP can be used for the diagnosis of gastric carcinoma

Study: HBV genotype is not linked to hepatocellular carcinoma

Study: HBV genotype is not linked to hepatocellular carcinoma

Bayer HealthCare to present its clinical trial data at a joint Multidisciplinary Congress

Bayer HealthCare to present its clinical trial data at a joint Multidisciplinary Congress

Multi-detector row computed tomography predicts malignancy of IPMNs

Multi-detector row computed tomography predicts malignancy of IPMNs

Toll-like receptors that activate immune cells being developed as alternative cure to cancer

Toll-like receptors that activate immune cells being developed as alternative cure to cancer

NCI-funded SPORE grant aims to improve kidney cancer treatment

NCI-funded SPORE grant aims to improve kidney cancer treatment

GlaxoSmithKline's Votrient will take significant market share away from Pfizer's Sutent by 2018

GlaxoSmithKline's Votrient will take significant market share away from Pfizer's Sutent by 2018

New critical illness plan from Colonial Life introduced

New critical illness plan from Colonial Life introduced

Results from Keryx' KRX-0401 Phase 2 study to be presented at the International Kidney Cancer Symposium

Results from Keryx' KRX-0401 Phase 2 study to be presented at the International Kidney Cancer Symposium

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.